+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Pharmacology of a potent long-acting imidazole-5-acrylic acid angiotensin II AT-1 receptor antagonist



Pharmacology of a potent long-acting imidazole-5-acrylic acid angiotensin II AT-1 receptor antagonist



FASEB Journal 8(4-5): A832




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 032784731

Download citation: RISBibTeXText


Related references

Pharmacology of a potent long-acting imidazole-5-acrylic acid angiotensin AT1 receptor antagonist. European Journal Of Pharmacology. 283(1-3): 63-72, 1995

A potent long-acting imidazole-5-acrylic acid angiotensin II AT-1 receptor antagonist. Bioorganic & Medicinal Chemistry Letters. 4(1): 23-28, 1994

Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1 biphenyl-4-yl-1H-benzimidazole-7-carboyxlic acid. Journal of Pharmacology & Experimental Therapeutics 266(1): 114-120, 1993

1-(carboxybenzyl)imidazole-5-acrylic acids: potent and selective angiotensin II receptor antagonists. Journal of Medicinal Chemistry 34(4): 1514-1517, 1991

Potent nonpeptide angiotensin II receptor antagonists: 2. 1-(Carboxybenzyl)imidazole-5-acrylic acids. Journal of Medicinal Chemistry 36(13): 1880-1892, 1993

Pharmacological Profiles of a Highly Potent and Long-Acting Angiotensin II Receptor Antagonist, Fimasartan, in Rats and Dogs after Oral Administration. Biological and Pharmaceutical Bulletin 40(7): 992, 2017

Topographic probes of angiotensin and receptor: potent angiotensin II agonist containing diphenylalanine and long-acting antagonists containing biphenylalanine and 2-indan amino acid in position 8. Journal of Medicinal Chemistry 32(4): 898-903, 1989

Antihypertensive effects of a highly potent and long-acting angiotensin II subtype-1 receptor antagonist, -1- ethyl 2-ethoxy-1- bipenyl-4-yl-methyl-1H-benzimidazole-7-carboxylate. Journal of Pharmacology & Experimental Therapeutics 268(3): 1540-1547, 1994

Imidazole-5-acrylic acids: Potent nonpeptide angiotensin II receptor antagonists designed using a novel peptide pharmacophore model. Journal of Medicinal Chemistry 35(21): 3858-3872, 1992

Antihypertensive effects of a highly potent and long-acting angiotensin II subtype-1 receptor antagonist, (+-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H- benzimidazole-7-carboxylate (TCV-116), in various hypertensive rats. Journal of Pharmacology and Experimental Therapeutics 268(3): 1540-1547, 1994

Pharmacology of KRH-594, a novel highly potent nonpeptide angiotensin II-receptor antagonist. FASEB Journal 11(3): A37, 1997

Pharmacology of sc 51895 a potent nonpeptidic angiotensin ii aii receptor antagonist. FASEB Journal 6(5): A1775, 1992

In vitro pharmacology of L-158,809, a new highly potent and selective angiotensin II receptor antagonist. Journal of Pharmacology and Experimental Therapeutics 262(1): 133-138, 1992

Pharmacology of XR510, a potent orally active nonpeptide angiotensin II AT1 receptor antagonist with high affinity for the AT2 receptor subtype. Journal of Cardiovascular Pharmacology 26(3): 354-362, 1995

WEB 2347: pharmacology of a new very potent and long acting hetrazepinoic PAF-antagonist and its action in repeatedly sensitized guinea-pigs. Journal of Lipid Mediators 4(1): 39-44, 1991